Pancreatic Enzyme Replacement and Nutritional Support With nab-Paclitaxel-based First-Line Chemotherapy Regimens in Metastatic Pancreatic Cancer.
Guido GiordanoRaffaele Ivan CincioneFrancesca LosavioTiziano SeniaArianna Aquilini MummoloMario PacilliVincenzo LizziGiuseppina BrunoAnnamaria PiscazziVincenza ConteducaMatteo LandriscinaPublished in: The oncologist (2023)
Our data suggest that an early and well-conducted NS in patients with mPC may impact on survival and preserve performance status, thus improving quality of life.